Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,867 | 118 | 98.8% |
| Education | $22.70 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $635.19 | 42 | $0 (2023) |
| Amgen Inc. | $411.32 | 23 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $208.03 | 15 | $0 (2020) |
| PFIZER INC. | $162.99 | 11 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $116.35 | 8 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71.10 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $63.02 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $61.42 | 5 | $0 (2019) |
| Lundbeck LLC | $39.82 | 3 | $0 (2018) |
| Boston Scientific Corporation | $37.78 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $75.69 | 4 | Novartis Pharmaceuticals Corporation ($39.08) |
| 2022 | $115.35 | 7 | Novartis Pharmaceuticals Corporation ($64.25) |
| 2021 | $58.34 | 4 | PFIZER INC. ($27.81) |
| 2020 | $182.68 | 11 | Janssen Pharmaceuticals, Inc ($49.22) |
| 2019 | $355.58 | 22 | Novartis Pharmaceuticals Corporation ($143.83) |
| 2018 | $516.51 | 36 | Novartis Pharmaceuticals Corporation ($159.55) |
| 2017 | $585.64 | 37 | Amgen Inc. ($275.47) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 03/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/03/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/04/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS, VYNDAQEL | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/22/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Cardiovascular | ||||||
| 05/11/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/09/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/02/2020 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Genetic Disease | ||||||
| 08/11/2020 | Preventice Services, LLC | — | Food and Beverage | Cash or cash equivalent | $19.39 | General |
| Category: Cardiovascular Monitors | ||||||
| 07/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Cardiovascular | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/14/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,741 | 2,585 | $996,950 | $70,355 |
| 2022 | 20 | 2,034 | 3,839 | $1.1M | $94,746 |
| 2021 | 22 | 2,292 | 4,480 | $1.4M | $123,407 |
| 2020 | 24 | 2,286 | 4,618 | $1.5M | $130,215 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 219 | 443 | $582,452 | $30,322 | 5.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 79 | $25,201 | $4,758 | 18.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 552 | 699 | $20,271 | $3,701 | 18.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 66 | 69 | $48,990 | $3,623 | 7.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 48 | 97 | $41,385 | $3,367 | 8.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 27 | 48 | $43,018 | $3,305 | 7.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 72 | 224 | $37,596 | $3,065 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $13,124 | $2,494 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 66 | $13,134 | $2,313 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $11,430 | $2,130 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 33 | $14,850 | $2,104 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,882 | $1,828 | 18.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 28 | $6,893 | $1,410 | 20.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 64 | 64 | $6,016 | $1,189 | 19.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 66 | 216 | $12,072 | $907.20 | 7.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 109 | 147 | $4,263 | $906.66 | 21.3% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 14 | 28 | $4,726 | $893.38 | 18.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 189 | 218 | $90,906 | $874.41 | 1.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $3,598 | $552.99 | 15.4% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 18 | 18 | $6,768 | $408.86 | 6.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 25 | $375.00 | $203.61 | 54.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 164 | 324 | $427,500 | $22,965 | 5.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 191 | $86,141 | $16,412 | 19.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 169 | 846 | $137,168 | $13,332 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $46,136 | $8,808 | 19.1% |
About Dr. Robert Morse, D.O
Dr. Robert Morse, D.O is a Internal Medicine healthcare provider based in Astoria, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174555312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Morse, D.O has received a total of $1,890 in payments from pharmaceutical and medical device companies, with $75.69 received in 2023. These payments were reported across 121 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,867).
As a Medicare-enrolled provider, Morse has provided services to 8,353 Medicare beneficiaries, totaling 15,522 services with total Medicare billing of $418,722. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Astoria, OR
- Active Since 07/07/2006
- Last Updated 09/28/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174555312
Products in Payments
- ENTRESTO (Drug) $548.42
- Corlanor (Drug) $258.48
- XARELTO (Drug) $208.03
- ELIQUIS (Drug) $206.26
- Repatha (Biological) $148.84
- LEQVIO (Drug) $86.77
- JARDIANCE (Drug) $56.10
- CHANTIX (Drug) $50.92
- PRALUENT ALIROCUMAB INJECTION (Biological) $48.97
- BRILINTA (Drug) $46.22
- NORTHERA (Drug) $39.82
- WATCHMAN (Device) $37.78
- Vascepa (Drug) $31.50
- VIAGRA (Drug) $22.16
- FARXIGA (Drug) $16.80
- PRALUENT (Drug) $16.21
- ONPATTRO (Drug) $15.67
- PRADAXA (Drug) $15.00
- PRALUENT (Biological) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Astoria
Dr. Jeffrey Klingenstein, Md, MD
Internal Medicine — Payments: $33,386
Dr. Rolando Borges, Md, MD
Internal Medicine — Payments: $17,840
Georgios Syros, M.d, M.D
Internal Medicine — Payments: $14,461
Dr. Richard Desmond, M.d, M.D
Internal Medicine — Payments: $12,122
Mukul Khurana, Md, MD
Internal Medicine — Payments: $7,368
Dr. Dan Cimponeriu, Md, MD
Internal Medicine — Payments: $6,469